These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18140837)

  • 21. In vitro susceptibility of Neisseria gonorrhoeae to the action of sulfamethoxypyridazine (kynex) and sulfadiazine.
    THAYER JD; FIELD FW; GARSON W
    Antibiot Chemother (Northfield); 1959 Mar; 9(3):176-9. PubMed ID: 24545155
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapeutic studies of 4-amino-4'-propylaminodiphenylsulfone alone and in combination with sulfadiazine in experimental pneumococcus infection.
    JUNGE JM; SMITH MI
    J Pharmacol Exp Ther; 1948 Mar; 92(3):352-61. PubMed ID: 18907223
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sensitivity of strains of Staphylococcus pyogenes isolated in Zagreb to penicillin and sulfadiazine].
    BEZJAK V
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1954; 6(3-4):304-9. PubMed ID: 13262719
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of human brucellosis caused by Br. Melitensis by the synergistic association streptomycin-sulfadiazine].
    JANBON M; BERTRAND L
    Presse Med (1893); 1949 Aug; 57(53):753. PubMed ID: 18140876
    [No Abstract]   [Full Text] [Related]  

  • 25. [Critical study of 17 cases of brucellosis treated with streptomycin associated or not with sulfadiazine].
    TAPIE J; LAPORTE J
    Paris Med; 1949 Sep; 39(33):401-11 !V17(49) R-00954. PubMed ID: 18139753
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of metabolites on the antitoxoplasmic action of pyrimethamine and sulfadiazine.
    EYLES DE; COLEMAN N
    Am J Trop Med Hyg; 1960 May; 9():277-83. PubMed ID: 13821130
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparisons of sulfisoxazole with sulfadiazine, and thiocymetin with chloramphenicol, in chemotherapy of experimental plague in mice.
    QUAN SF; MCMANUS AG; MEYER KF
    Am J Trop Med Hyg; 1955 Nov; 4(6):1028-36. PubMed ID: 13268809
    [No Abstract]   [Full Text] [Related]  

  • 28. [CERTAIN MICROBIOLOGICAL PECULIARITIES OF NEW SULFANILAMIDES].
    KUTZSCHE A
    Chemotherapia (Basel); 1964; 64():53-62. PubMed ID: 14178045
    [No Abstract]   [Full Text] [Related]  

  • 29. The susceptibility of 168 strains of salmonellae to eleven anti-microbial agents.
    Sng EH; Lam S
    Singapore Med J; 1971 Feb; 12(1):8-12. PubMed ID: 4325813
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combination of stylomycin aminonucleoside and sulfadiazine in experimental toxoplasmosis in the mouse].
    CAMARGO EP; das CARNEIRO MN; da SILVA L
    Rev Inst Med Trop Sao Paulo; 1961; 3():166-74. PubMed ID: 13875896
    [No Abstract]   [Full Text] [Related]  

  • 31. Infectious drug resistance in shigellae in Cape Town.
    Watson CE
    S Afr Med J; 1967 Aug; 41(29):728-31. PubMed ID: 4860815
    [No Abstract]   [Full Text] [Related]  

  • 32. [The in vitro sensitivity of Bacteroidies melaninogenicus to the commonly used antibiotics and sulfonamide (Penicillin, streptomycin, chloramphenicol, tetracycline, oxytetracline, chlorteracycline, erythromycin, inmycin, oleandomycin, selectomycin, polymixin B, supronal, aristamid and lederkyn)].
    PULVERER G; HEINRICH S
    Z Hyg Infektionskr; 1959; 146():1-7. PubMed ID: 14435313
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro effects on gram-negative bacteria of streptomycin combined with penicillin and/ or sulfadiazine.
    PULASKI EJ; BAKER HJ
    J Lab Clin Med; 1949 Feb; 34(2):186-98. PubMed ID: 18109450
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfadiazine and sulfamerazine in combined sulfonamide therapy.
    KANTOR TG
    N Y State J Med; 1950 May; 50(10):1237-40. PubMed ID: 15416947
    [No Abstract]   [Full Text] [Related]  

  • 35. [Investigations on the bacteriostatic effect of protocid, supronal, penicillin and streptomycin].
    SPIELMANN H
    Med Klin; 1951 Mar; 46(11):317-21. PubMed ID: 14842518
    [No Abstract]   [Full Text] [Related]  

  • 36. Acquired resistance of psittacosis virus to sulfadiazine and effects of chemical antagonists on sulfonamide activity.
    GOLUB OJ
    J Lab Clin Med; 1948 Oct; 33(10):1241-8. PubMed ID: 18886321
    [No Abstract]   [Full Text] [Related]  

  • 37. Derivation and properties of Proteus mirabilis systems for high frequency transduction of streptomycin--sulphonamide and streptomycin-sulphonamide--kanamycin resistances.
    Coetzee JN
    J Gen Microbiol; 1976 Sep; 96(1):95=107. PubMed ID: 789816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effect of sulphadiazine and dihydrotriazines against blood-induced P. cynomolgy infection.
    NAIR CP; RAY AP; SINGH J
    Indian J Malariol; 1956 Jun; 10(2):131-5. PubMed ID: 13366405
    [No Abstract]   [Full Text] [Related]  

  • 39. [A simple, clinically useful method of determining bacterial resistance to penicillin, streptomycin and sulfonamides].
    EUFINGER H; MOLLOWITZ G
    Chirurg; 1951 Jan; 22(1):11-6. PubMed ID: 14812617
    [No Abstract]   [Full Text] [Related]  

  • 40. [ANTIBACTERIAL SULFONAMIDES].
    TREFOUEL J
    Prod Probl Pharm; 1964 Jan; 19():3-14. PubMed ID: 14135919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.